Your browser doesn't support javascript.
loading
[Cytokines in systemic sclerosis]. / Les cytokines dans la sclérodermie systémique.
Baraut, J; Farge, D; Jean-Louis, F; Kesmandt, H; Durant, C; Verrecchia, F; Michel, L.
  • Baraut J; hôpital Saint-Louis. pavillon Bazin, Paris, France.
Pathol Biol (Paris) ; 60(2): 127-39, 2012 Apr.
Article en Fr | MEDLINE | ID: mdl-20116938
ABSTRACT
The balance in the production and release of cytokines "Th1/Th2" or "Th17" or "regulatory T" is one of the key events in the pathogenesis of systemic sclerosis (SSc). Specifically, the Th2 cytokine response, characterized by the production of IL-4, IL-10 and TGF-ß, leads to tissue fibrosis in patients with SSc. Many studies have shown the importance of analyzing the levels of cytokines as diagnostic or prognostic markers in the blood or in situ in patients with SSc. The restoration of the Th1/Th2/Th17/Treg balance will contribute to the effectiveness of treatment and the use of cytokine modulators may therefore be considered in developing new therapeutic approaches.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Citocinas Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Humans Idioma: Fr Año: 2012 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Esclerodermia Sistémica / Citocinas Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Humans Idioma: Fr Año: 2012 Tipo del documento: Article